Tier 2 · Liquid 3000

LIGAND PHARMACEUTICALS INC

LGND · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$303.39
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0000886163
Liquidity rank
#1106
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$268.09M2025-12-310000886163-26-000006
Annual diluted EPS6.132025-12-310000886163-26-000006
Quarterly revenue$51.72M2026-03-310000886163-26-000034
Quarterly diluted EPS-0.672026-03-310000886163-26-000034

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.065Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-07-19 through 2026-07-19.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo FinanceYahoo Finance · 2026-07-17
Market expert healthcare poised for ‘significant upside’ earnings surprise - qz.comqz.com · 2026-07-17
Four-property Kansas City medical building portfolio trades hands - JLLJLL · 2026-07-16
Congress can finish the job on healthcare price transparency - The Washington PostThe Washington Post · 2026-07-16
Why Healthcare Stocks Look Like a Haven in This Market - Barron'sBarron's · 2026-07-16

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames